NECVAX-NEO1

· NEC OncoImmunity AS

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for NECVAX-NEO1, covering 2025-06-26 to 2026-02-20. Get the full timeline:

Most recent: Clinical Trial Update: Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Neoadjuvant Triple-negative Breast Cancer [Phase 1, Phase 2]

See pricing